These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 25609114)

  • 1. New agents for thromboprotection. A role for factor XII and XIIa inhibition.
    Labberton L; Kenne E; Renné T
    Hamostaseologie; 2015; 35(4):338-50. PubMed ID: 25609114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The polyphosphate/factor XII pathway in cancer-associated thrombosis: novel perspectives for safe anticoagulation in patients with malignancies.
    Nickel KF; Labberton L; Long AT; Langer F; Fuchs TA; Stavrou EX; Butler LM; Renné T
    Thromb Res; 2016 May; 141 Suppl 2():S4-7. PubMed ID: 27207422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor XII: a novel target for safe prevention of thrombosis and inflammation.
    Kenne E; Nickel KF; Long AT; Fuchs TA; Stavrou EX; Stahl FR; Renné T
    J Intern Med; 2015 Dec; 278(6):571-85. PubMed ID: 26373901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet polyphosphates: the nexus of primary and secondary hemostasis.
    Müller F; Renné T
    Scand J Clin Lab Invest; 2011 Apr; 71(2):82-6. PubMed ID: 21385010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel roles for factor XII-driven plasma contact activation system.
    Müller F; Renné T
    Curr Opin Hematol; 2008 Sep; 15(5):516-21. PubMed ID: 18695377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation factor XII in thrombosis and inflammation.
    Maas C; Renné T
    Blood; 2018 Apr; 131(17):1903-1909. PubMed ID: 29483100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor XI and XII as antithrombotic targets.
    Müller F; Gailani D; Renné T
    Curr Opin Hematol; 2011 Sep; 18(5):349-55. PubMed ID: 21730835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XII: a drug target for safe interference with thrombosis and inflammation.
    Kenne E; Renné T
    Drug Discov Today; 2014 Sep; 19(9):1459-64. PubMed ID: 24993156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
    Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis.
    Nickel KF; Ronquist G; Langer F; Labberton L; Fuchs TA; Bokemeyer C; Sauter G; Graefen M; Mackman N; Stavrou EX; Ronquist G; Renné T
    Blood; 2015 Sep; 126(11):1379-89. PubMed ID: 26153520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing blood-borne polyphosphate in vivo provides safe thromboprotection.
    Labberton L; Kenne E; Long AT; Nickel KF; Di Gennaro A; Rigg RA; Hernandez JS; Butler L; Maas C; Stavrou EX; Renné T
    Nat Commun; 2016 Sep; 7():12616. PubMed ID: 27596064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Factor XII in hemostasis and thrombosis: clinical implications.
    Renné T; Gailani D
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):733-41. PubMed ID: 17605651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer.
    Woodruff RS; Xu Y; Layzer J; Wu W; Ogletree ML; Sullenger BA
    J Thromb Haemost; 2013 Jul; 11(7):1364-73. PubMed ID: 23692437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XII-mediated contact activation related to poor prognosis in disseminated intravascular coagulation.
    Park HS; Gu J; You HJ; Kim JE; Kim HK
    Thromb Res; 2016 Feb; 138():103-107. PubMed ID: 26706311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrinsic pathway of coagulation and arterial thrombosis.
    Gailani D; Renné T
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contact system revisited: an interface between inflammation, coagulation, and innate immunity.
    Long AT; Kenne E; Jung R; Fuchs TA; Renné T
    J Thromb Haemost; 2016 Mar; 14(3):427-37. PubMed ID: 26707513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the contact pathway in thrombus propagation.
    Gruber A
    Thromb Res; 2014 May; 133 Suppl 1():S45-7. PubMed ID: 24759142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
    Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
    Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The procoagulant and proinflammatory plasma contact system.
    Renné T
    Semin Immunopathol; 2012 Jan; 34(1):31-41. PubMed ID: 21858560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XII regulates the pathological process of thrombus formation on ruptured plaques.
    Kuijpers MJ; van der Meijden PE; Feijge MA; Mattheij NJ; May F; Govers-Riemslag J; Meijers JC; Heemskerk JW; Renné T; Cosemans JM
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1674-80. PubMed ID: 24855058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.